Guardant Health (GH)Director filed to sell ~$19K

~$19K

planned to sell · 116 shares, around Oct 16, 2026

Planned for

Oct 16, 2026

Notice filed

Oct 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 28, 2026CongressDisclosed purchase of GH — reported range $15,001 - $50,000
2. Oct 14, 2026InsiderDirector sold ~$11K of GH shares in the open market
3. Oct 16, 2026InsiderDirector sold ~$19K of GH shares in the open market

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Guardant Health

For Guardant Health, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 23 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GH page.

How this filing works

• SEC Form 144
• Rule 10b5-1 trading plans

Other disclosures at Guardant Health

• SEC Form 4Oct 19, 2026
• SEC Form 4Oct 15, 2026
• SEC Form 144Oct 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its GH page.